|
|
|
|
|
by explaininjs
901 days ago
|
|
Honestly that’s even worse. So there’s a successful company that has no problem selling its products for tens of thousands of dollars as part of a perpetuation of the insurance-industrial complex whereby folks without access to “good insurance” can’t receive simple, potentially life saving analysis, but they refuse to pay their engineers fair compensation. So then the engineers try to go to a place where they will recice fair compensation and far more people will have access to the life saving equipment they developed, but the CEO of their old company throws a hissy fit over the technology being accessible to folks besides the ultra wealthy and sues them. Disgusting. |
|
Masimo makes as you note, industrial devices. The Root devices that I mention are not ever going to be used at home, even by the ultra wealthy.
I mean you are talking about devices that do CO-oximetry (effectively "arterial blood gas"), brain function monitoring, connect to ventilators (ISA capnography for intubated patients) and anesthesia machines and pushing aggregated data into EPIC. Like I said, these are devices being used in intensive care units, not simple finger pulse oximetry, reflected or otherwise.
They are not "gatekeeping" this technology for the ultra wealthy so poor Apple Watch owners (of which I am on my third) can't get access to it. They're entirely different models with different purposes, in an entirely differing market segment.
Also if you're referring to "potentially life saving analysis" with respect to pulse oximetry on the Apple Watch, which does it only on demand, and is not an FDA regulated medical device, regardless of patents, there's an exaggeration happening. Patients with chronic hypoxic and similar issues are not relying on Apple Watches to "potentially save their lives".